|
Session 39
Oral Abstracts
Hepatitis B and C: Epidemiology, Pathogenesis, and Treatment
Wednesday, 10 - 11:45 am
Room: Room 515 |
| 10:00 am 130 |
Acute Hepatitis C in Men Who Have Sex With Men Is Not Confined to Those Infected with HIV, and Their Number Continues to Increase
Martin Fisher*1, D Richardson1, and C Sabin2
1Royal Sussex County Hosp, Brighton, UK and 2Royal Free and Univ Coll London Med Sch, UK |
| 10:15 am 131 |
The Dynamics of HCV Transmission among Injection Drug Users in St. Petersburg, Russia: Sexual Transmission and Acquisition of HIV Cooperative Agreement Program
Elijah Paintsil*1, N Abdala1, L Niccolai1, E Dukhovlinova2, O Toussova2, S Verevochkin2, L Alexander3, A Kozlov2, and R Heimer1
1Yale Univ, New Haven, CT, US; 2Biomed Ctr, St Petersburg, Russia; and 3Bristol-Myers Squibb, Wallingford, CT, US |
| 10:30 am 132 |
HCV-specific CD8+ T Cells Produce TGF-b that Suppresses HCV-specific T-cell Responses of HCV-mono-infected and HIV-co-infected Subjects
Nadia Alatrakchi*, C Graham, M Exley, and M Koziel
Beth Israel Deaconess Med Ctr, Harvard Med Sch, Boston, MA, US |
| 10:45 am 133 |
HIV-specific T Cells Accumulate in the Liver in HCV/HIV Co-infection
F Yue, B Valli, D Wong, J Heathcote, C Kovacs, M Loutfy, R Gray, R Halpenny, and Mario Ostrowski*
Univ of Toronto, Canada |
| 11:00 am 134 |
CpG Adjuvant + HBV Vaccination in HIV Infection Achieves Long-term Seroprotection for as Long as 5 Years
Curtis Cooper*1, J Angel1, I Seguin1, D Cote1, H Davis2, and D Cameron1
1Ottawa Hosp, Univ of Ottawa, Canada and 2Coley Pharma Group, Ottawa, Canada and Wellesley, MA, US |
| 11:15 am 135 |
Selection of HBV-resistant Mutants in HIV/HBV-co-infected Patients Failing ART with Anti-HBV Activity: Implications for Diagnostic and Vaccine Escape
Julie Sheldon*1, B Ramos1, A Bartholomeusz2, J Garcia-Samaniego1, P Rios1, M Romero1, S Locarnini2, and V Soriano1
1Hosp Carlos III, Madrid, Spain and 2Victorian Infectious Diseases Reference Lab, North Melbourne, Australia |
| 11:30 am 136LB |
The Anti-Hepatitis B Drug Entecavir Inhibits HIV-1 Replication and Selects HIV-1 Variants Resistant to Antiretroviral Drugs
M McMahon1, B Jilek1, T Brennan1, L Shen1, Y Zhou1, S Bhat1, B Hale2, R Hegarty1, R Silicano1, and Chloe Thio*1
1Johns Hopkins Univ, Baltimore, MD, US and 2Naval Med Ctr |
|
